3 best performing ASX shares in the week of 4 July 2022
Marc Kennis, July 11, 2022
Best performing ASX shares
The three best performing ASX shares in the week of 4 July 2022 were IOUpay (ASX:IOU), up 97.8%, Province Resources (ASX:PRL), up 65.5%, and Eroad (ASX:ERD), up 65.4%.
No time to do stock research, but you still want to invest?
Stocks Down Under Concierge gives you timely BUY and SELL alerts on ASX-listed stocks!
GET A 3-MONTH FREE TRIAL TO CONCIERGE TODAY
1. IOUpay (ASX:IOU)
Industry: FinTech
IOUpay Limited (ASX:IOU, formerly Isentric Limited) provides fintech and digital commerce software solutions and services that enable its institutional customers to securely authenticate end-user customers and process banking, purchase and payment transactions. The company’s business divisions consist of Mobile Banking, Digital Payments and Digital Services.
Market Cap: $50m
12 month high / low: $0.038 – $0.375

2. Province Resources (ASX:PRL)
Industry: Resources
Province Resources Ltd (ASX:PRL, formerly ScandiVanadium) is an natural resources company currently focused on the mineral exploration and development of copper, gold, nickel, cobalt, vanadium and other mineral opportunities.
Market Cap: $107M
12 month high / low: $0.05 – $0.195

3. Eroad (ASX:ERD)
Industry: Technology
EROAD Limited (ASX:ERD) develops and markets technology solutions to manage vehicle fleets, support regulatory compliance, improve driver safety and reduce the costs associated with operating a fleet of vehicles and inventory of assets. EROAD has a proven SaaS business model and is experiencing continuing growth in installed units and revenue.
Market Cap: $238m
12 month high / low: $1.26 – $6.51

No time to do stock research, but you still want to invest?
Stocks Down Under Concierge gives you timely BUY and SELL alerts on ASX-listed stocks!
GET A 3-MONTH FREE TRIAL TO CONCIERGE TODAY
No credit card needed and the trial expires automatically.

Blog Categories
Get Our Top 5 ASX Stocks for FY26
Recent Posts
Imricor Medical (ASX:IMR) FDA Approval Ignites Shares, but the Real Test Starts Now
FDA Approval Is a Big Win, Not the Finish Line Imricor Medical (ASX:IMR) received FDA clearance for its Vision-MR diagnostic…
How Nuclear Energy Became the World’s Most Feared Energy Source
Why Nuclear Energy Still Scares Us and What Really Went Wrong Many investors may remember periods when nuclear energy captured…
Dateline Resources (ASX:DTR) From 60c Highs to Hard Lessons
A Rare Earth Story the Market Loved Then Questioned For investors who have followed Dateline Resources (ASX:DTR), the past year…